Name
Breakfast & Clinical Update: XOSPATA® (gilteritinib): A Targeted Therapeutic Approach for Relapsed/Refractory FLT3m+ AML Patients
Date & Time
Saturday, March 2, 2019, 8:15 AM - 9:00 AM
Speakers
Jeff Klaus, PharmD - Astellas
Jeff Klaus, PharmD
Location Name
Grand Ballroom
Full Address
Sheraton Denver Downtown Hotel
1550 Court Pl
Denver, Colorado 80202
United States